(1->4)-beta-D-glucan multiple interactions ISO RGD:1624065 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TUBA1B mRNA CTD PMID:36331819 (S)-colchicine decreases expression EXP 6480464 Colchicine results in decreased expression of TUBA1B mRNA CTD PMID:20624997 1,1-dichloroethene increases expression ISO RGD:1624065 6480464 vinylidene chloride results in increased expression of TUBA1B mRNA CTD PMID:26682919 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of TUBA1B mRNA CTD PMID:30723492 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of TUBA1B mRNA CTD PMID:17108234 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1624065 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1624065 6480464 Tetrachlorodibenzodioxin affects the expression of TUBA1B mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of TUBA1B mRNA CTD PMID:32109520 , PMID:34747641 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:19954255 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1624065 6480464 tetrabromobisphenol A results in decreased expression of TUBA1B mRNA CTD PMID:25172293 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1603700 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TUBA1B mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TUBA1B mRNA CTD PMID:28628672 4-hydroxynon-2-enal affects binding ISO RGD:1603700 6480464 TUBA1B protein binds to 4-hydroxy-2-nonenal CTD PMID:20043646 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of TUBA1B mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of TUBA1B mRNA CTD PMID:31881176 acrolein multiple interactions ISO RGD:1603700 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of TUBA1B mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of TUBA1B mRNA CTD PMID:32699268 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of TUBA1B mRNA CTD PMID:28959563 acrylamide decreases expression ISO RGD:1603700 6480464 Acrylamide results in decreased expression of TUBA1B mRNA CTD PMID:32763439 aflatoxin B1 decreases methylation ISO RGD:1603700 6480464 Aflatoxin B1 results in decreased methylation of TUBA1B exon CTD PMID:30157460 alpha-pinene multiple interactions ISO RGD:1603700 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of TUBA1B mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of TUBA1B mRNA CTD PMID:32699268 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of TUBA1B mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:1603700 6480464 Antirheumatic Agents results in decreased expression of TUBA1B mRNA CTD PMID:24449571 arsenite(3-) multiple interactions ISO RGD:1603700 6480464 arsenite promotes the reaction [G3BP1 protein binds to TUBA1B mRNA] CTD PMID:32406909 arsenous acid increases expression ISO RGD:1603700 6480464 Arsenic Trioxide results in increased expression of TUBA1B mRNA CTD PMID:20458559 azathioprine decreases expression ISO RGD:1603700 6480464 Azathioprine results in decreased expression of TUBA1B mRNA CTD PMID:22623647 azoxystrobin increases expression ISO RGD:1603700 6480464 azoxystrobin results in increased expression of TUBA1B mRNA CTD PMID:33512557 beauvericin multiple interactions ISO RGD:1603700 6480464 [beauvericin co-treated with enniatins] results in increased expression of TUBA1B protein CTD PMID:32407736 benzo[a]pyrene affects methylation ISO RGD:1603700 6480464 Benzo(a)pyrene affects the methylation of TUBA1B promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1603700 6480464 Benzo(a)pyrene results in increased expression of TUBA1B mRNA CTD PMID:32234424 benzo[b]fluoranthene increases expression ISO RGD:1624065 6480464 benzo(b)fluoranthene results in increased expression of TUBA1B mRNA CTD PMID:26377693 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of TUBA1B mRNA CTD PMID:20920545 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of TUBA1B mRNA CTD PMID:25181051 bisphenol A affects expression ISO RGD:1603700 6480464 bisphenol A affects the expression of TUBA1B mRNA CTD PMID:30903817 bisphenol A multiple interactions ISO RGD:1603700 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TUBA1B mRNA CTD PMID:28628672 bisphenol F multiple interactions ISO RGD:1603700 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TUBA1B mRNA CTD PMID:28628672 caffeine decreases phosphorylation ISO RGD:1603700 6480464 Caffeine results in decreased phosphorylation of TUBA1B protein CTD PMID:35688186 carbon nanotube decreases expression ISO RGD:1624065 6480464 Nanotubes, Carbon analog results in decreased expression of TUBA1B mRNA CTD PMID:25620056 carbon nanotube increases expression ISO RGD:1624065 6480464 Nanotubes more ... CTD PMID:25554681 chloropicrin increases expression ISO RGD:1603700 6480464 chloropicrin results in increased expression of TUBA1B mRNA CTD PMID:26352163 clobetasol increases expression ISO RGD:1624065 6480464 Clobetasol results in increased expression of TUBA1B mRNA CTD PMID:27462272 copper atom multiple interactions ISO RGD:1603700 6480464 [Chelating Agents binds to Copper] which results in decreased expression of TUBA1B mRNA, [NSC 689534 binds to Copper] which results in decreased expression of TUBA1B mRNA CTD PMID:20971185 , PMID:30911355 copper(0) multiple interactions ISO RGD:1603700 6480464 [Chelating Agents binds to Copper] which results in decreased expression of TUBA1B mRNA, [NSC 689534 binds to Copper] which results in decreased expression of TUBA1B mRNA CTD PMID:20971185 , PMID:30911355 copper(II) sulfate decreases expression ISO RGD:1603700 6480464 Copper Sulfate results in decreased expression of TUBA1B mRNA CTD PMID:19549813 coumarin increases phosphorylation ISO RGD:1603700 6480464 coumarin results in increased phosphorylation of TUBA1B protein CTD PMID:35688186 crocidolite asbestos increases expression ISO RGD:1603700 6480464 Asbestos, Crocidolite results in increased expression of TUBA1B protein CTD PMID:29553831 cyclosporin A increases expression ISO RGD:1603700 6480464 Cyclosporine results in increased expression of TUBA1B mRNA CTD PMID:25562108 decabromodiphenyl ether decreases expression ISO RGD:1603700 6480464 decabromobiphenyl ether results in decreased expression of TUBA1B protein CTD PMID:31675489 dexamethasone multiple interactions ISO RGD:1603700 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TUBA1B mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TUBA1B mRNA CTD PMID:28628672 diallyl trisulfide decreases expression ISO RGD:1603700 6480464 diallyl trisulfide results in decreased expression of TUBA1B mRNA CTD PMID:34995734 diarsenic trioxide increases expression ISO RGD:1603700 6480464 Arsenic Trioxide results in increased expression of TUBA1B mRNA CTD PMID:20458559 dibutyl phthalate decreases expression ISO RGD:1624065 6480464 Dibutyl Phthalate results in decreased expression of TUBA1B mRNA CTD PMID:21266533 dioxygen decreases expression ISO RGD:1603700 6480464 Oxygen deficiency results in decreased expression of TUBA1B mRNA CTD PMID:26516004 elemental selenium increases expression ISO RGD:1603700 6480464 Selenium results in increased expression of TUBA1B mRNA CTD PMID:19244175 enniatin multiple interactions ISO RGD:1603700 6480464 [beauvericin co-treated with enniatins] results in increased expression of TUBA1B protein CTD PMID:32407736 enzyme inhibitor multiple interactions ISO RGD:1603700 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TUBA1B protein CTD PMID:23301498 ethanol multiple interactions ISO RGD:1624065 6480464 Ethanol affects the expression of and affects the splicing of TUBA1B mRNA CTD PMID:30319688 fenbuconazole increases expression ISO RGD:1603700 6480464 fenbuconazole results in increased expression of TUBA1B mRNA CTD PMID:15942997 folic acid decreases expression ISO RGD:1624065 6480464 Folic Acid results in decreased expression of TUBA1B mRNA CTD PMID:25006883 fulvestrant increases expression ISO RGD:1603700 6480464 fulvestrant results in increased expression of TUBA1B mRNA CTD PMID:12154049 furan increases expression ISO RGD:1624065 6480464 furan results in increased expression of TUBA1B mRNA CTD PMID:24183702 glyphosate decreases expression ISO RGD:1603700 6480464 glyphosate results in decreased expression of TUBA1B mRNA CTD PMID:31295307 hydrogen peroxide multiple interactions ISO RGD:1603700 6480464 [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of TUBA1B protein CTD PMID:18951874 hydrogen peroxide decreases expression ISO RGD:1603700 6480464 Hydrogen Peroxide results in decreased expression of TUBA1B mRNA CTD PMID:12419474 hydrogen sulfide decreases expression ISO RGD:1624065 6480464 Hydrogen Sulfide results in decreased expression of TUBA1B protein CTD PMID:29932956 indometacin multiple interactions ISO RGD:1603700 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TUBA1B mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TUBA1B mRNA CTD PMID:28628672 isoprenaline decreases expression ISO RGD:1624065 6480464 Isoproterenol results in decreased expression of TUBA1B mRNA CTD PMID:20003209 ivermectin decreases expression ISO RGD:1603700 6480464 Ivermectin results in decreased expression of TUBA1B protein CTD PMID:32959892 leflunomide decreases expression ISO RGD:1603700 6480464 leflunomide results in decreased expression of TUBA1B mRNA CTD PMID:28988120 lipopolysaccharide multiple interactions ISO RGD:1624065 6480464 [stearic acid co-treated with Lipopolysaccharides] affects the acylation of TUBA1B protein CTD PMID:33810233 lipopolysaccharide multiple interactions ISO RGD:1603700 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of TUBA1B mRNA CTD PMID:35877022 lovastatin increases expression ISO RGD:1624065 6480464 Lovastatin results in increased expression of TUBA1B mRNA CTD PMID:20493250 lovastatin decreases expression ISO RGD:1624065 6480464 Lovastatin results in decreased expression of TUBA1B mRNA CTD PMID:20493250 maneb multiple interactions ISO RGD:1624065 6480464 [Paraquat co-treated with Maneb] results in decreased expression of TUBA1B mRNA CTD PMID:18386188 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of TUBA1B protein CTD PMID:19826936 miconazole increases expression ISO RGD:1624065 6480464 Miconazole results in increased expression of TUBA1B mRNA CTD PMID:27462272 N-methyl-4-phenylpyridinium increases expression ISO RGD:1603700 6480464 1-Methyl-4-phenylpyridinium results in increased expression of TUBA1B protein CTD PMID:24675778 N-methyl-D-aspartic acid multiple interactions ISO RGD:1624065 6480464 N-Methylaspartate inhibits the reaction [gelsenicine results in increased phosphorylation of TUBA1B protein] CTD PMID:34389372 Nivalenol decreases acetylation ISO RGD:1624065 6480464 nivalenol results in decreased acetylation of TUBA1B protein CTD PMID:35016910 octadecanoic acid multiple interactions ISO RGD:1624065 6480464 [stearic acid co-treated with Lipopolysaccharides] affects the acylation of TUBA1B protein CTD PMID:33810233 ozone multiple interactions ISO RGD:1603700 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of TUBA1B mRNA more ... CTD PMID:32699268 ozone multiple interactions ISO RGD:1624065 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TUBA1B mRNA CTD PMID:34911549 paraquat multiple interactions ISO RGD:1624065 6480464 [Paraquat co-treated with Maneb] results in decreased expression of TUBA1B mRNA CTD PMID:18386188 paraquat decreases expression ISO RGD:1603700 6480464 Paraquat results in decreased expression of TUBA1B mRNA CTD PMID:35182771 PCB138 decreases expression EXP 6480464 2 more ... CTD PMID:21673325 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1624065 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TUBA1B mRNA CTD PMID:36331819 perfluorooctanoic acid decreases expression ISO RGD:1603700 6480464 perfluorooctanoic acid results in decreased expression of TUBA1B mRNA CTD PMID:36326898 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of TUBA1B mRNA CTD PMID:19162173 picoxystrobin increases expression ISO RGD:1603700 6480464 picoxystrobin results in increased expression of TUBA1B mRNA CTD PMID:33512557 pinosylvin decreases expression ISO RGD:1603700 6480464 pinosylvin results in decreased expression of TUBA1B mRNA CTD PMID:23333577 raloxifene increases expression ISO RGD:1603700 6480464 Raloxifene Hydrochloride results in increased expression of TUBA1B mRNA CTD PMID:12154049 rotenone multiple interactions ISO RGD:1624065 6480464 TRP53 affects the reaction [Rotenone affects the expression of TUBA1B mRNA] CTD PMID:21893155 rotenone increases expression ISO RGD:1603700 6480464 Rotenone results in increased expression of TUBA1B mRNA CTD PMID:33512557 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of TUBA1B mRNA CTD PMID:28374803 rotenone increases oxidation EXP 6480464 Rotenone results in increased oxidation of TUBA1B protein CTD PMID:30951809 rotenone affects expression ISO RGD:1624065 6480464 Rotenone affects the expression of TUBA1B mRNA CTD PMID:21893155 selenium atom increases expression ISO RGD:1603700 6480464 Selenium results in increased expression of TUBA1B mRNA CTD PMID:19244175 sevoflurane affects expression EXP 6480464 sevoflurane affects the expression of TUBA1B mRNA CTD PMID:15967596 silicon dioxide affects secretion ISO RGD:1603700 6480464 Silicon Dioxide analog affects the secretion of TUBA1B protein CTD PMID:25895662 silicon dioxide multiple interactions ISO RGD:1603700 6480464 BMI1 protein inhibits the reaction [Silicon Dioxide results in decreased acetylation of TUBA1B protein] CTD PMID:35288261 silicon dioxide decreases acetylation ISO RGD:1624065 6480464 Silicon Dioxide results in decreased acetylation of TUBA1B protein CTD PMID:35288261 silicon dioxide decreases acetylation ISO RGD:1603700 6480464 Silicon Dioxide results in decreased acetylation of TUBA1B protein CTD PMID:35288261 sodium arsenite increases expression ISO RGD:1603700 6480464 sodium arsenite results in increased expression of TUBA1B mRNA CTD PMID:28595984 , PMID:34032870 sodium dichromate decreases expression ISO RGD:1624065 6480464 sodium bichromate results in decreased expression of TUBA1B mRNA CTD PMID:31558096 sodium fluoride increases expression ISO RGD:1624065 6480464 Sodium Fluoride results in increased expression of TUBA1B protein CTD PMID:27548804 sunitinib decreases expression ISO RGD:1603700 6480464 Sunitinib results in decreased expression of TUBA1B mRNA CTD PMID:31533062 tert-butyl hydroperoxide decreases expression ISO RGD:1603700 6480464 tert-Butylhydroperoxide results in decreased expression of TUBA1B mRNA, tert-Butylhydroperoxide results in decreased expression of TUBA1B protein CTD PMID:12419474 , PMID:15050405 theophylline multiple interactions ISO RGD:1603700 6480464 [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of TUBA1B protein CTD PMID:18951874 trans-pinosylvin decreases expression ISO RGD:1603700 6480464 pinosylvin results in decreased expression of TUBA1B mRNA CTD PMID:23333577 tris(2-butoxyethyl) phosphate affects expression ISO RGD:1603700 6480464 tris(2-butoxyethyl) phosphate affects the expression of TUBA1B mRNA CTD PMID:29024780 tungsten increases expression ISO RGD:1624065 6480464 Tungsten results in increased expression of TUBA1B mRNA CTD PMID:30912803 tunicamycin decreases expression ISO RGD:1603700 6480464 Tunicamycin results in decreased expression of TUBA1B mRNA CTD PMID:22378314 urethane decreases expression ISO RGD:1603700 6480464 Urethane results in decreased expression of TUBA1B mRNA CTD PMID:28818685 vincaleukoblastine decreases expression EXP 6480464 Vinblastine results in decreased expression of TUBA1B mRNA CTD PMID:20624997 vincristine decreases expression ISO RGD:1603700 6480464 Vincristine results in decreased expression of TUBA1B mRNA CTD PMID:23649840 vincristine decreases expression EXP 6480464 Vincristine results in decreased expression of TUBA1B mRNA CTD PMID:20624997 vitamin E increases expression ISO RGD:1603700 6480464 Vitamin E results in increased expression of TUBA1B mRNA CTD PMID:19244175 warfarin decreases expression ISO RGD:1624065 6480464 Warfarin results in decreased expression of TUBA1B mRNA CTD PMID:20493250 warfarin increases expression ISO RGD:1624065 6480464 Warfarin results in increased expression of TUBA1B mRNA CTD PMID:20493250 zinc dichloride increases expression ISO RGD:1603700 6480464 zinc chloride results in increased expression of TUBA1B mRNA CTD PMID:18947441 zoledronic acid decreases expression ISO RGD:1603700 6480464 zoledronic acid results in decreased expression of TUBA1B mRNA CTD PMID:24714768